デフォルト表紙
市場調査レポート
商品コード
1529687

獣医臨床試験の市場規模、シェア、動向分析レポート:動物別、適応症別、介入別、スポンサー別、地域別、セグメント別予測、2024年~2030年

Veterinary Clinical Trials Market Size, Share & Trends Analysis Report By Animal (Companion Animal, Livestock Animal, Other Animals), By Indication, By Intervention, By Sponsor, By Region, And Segment Forecasts, 2024 - 2030


出版日
ページ情報
英文 150 Pages
納期
2~10営業日
カスタマイズ可能
獣医臨床試験の市場規模、シェア、動向分析レポート:動物別、適応症別、介入別、スポンサー別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年07月08日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示

  • 概要
  • 図表
  • 目次
概要

獣医臨床試験市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の獣医臨床試験市場規模は2030年までに89億9,000万米ドルに達し、2024年から2030年までのCAGRは9.0%に達すると予測されています。

業界の成長を促進する主な要因は、主要企業による研究開発費の増加、動物の慢性疾患の有病率の上昇、動物用医薬品の進歩、戦略的提携の増加などです。例えば、2024年4月、ヒトと動物の両方の健康に焦点を当てたバイオ医薬品会社であるベーリンガーインゲルハイムは、動物用臨床試験を加速し、革新的な動物用医薬品を開発するために、動物用医薬品の研究開発に5億9,350万米ドルを投資しました。

さらに、ペットの希少疾患の臨床試験の増加が獣医臨床試験市場を牽引すると予想されます。動物病院や研究機関は、犬の希少がんに特化した専門的な臨床試験の取り組みを行っています。これらの臨床試験は、標的療法、免疫療法、個々の犬の遺伝子プロファイルに合わせて設計された精密医療技術など、新しい治療アプローチを調査することを目的としています。例えば、ビベスト社は2024年3月、犬の脾臓血管肉腫を対象とした臨床試験Paccal Vetを開始しました。この臨床試験は、XR-17技術で製剤化されたPaccal Vetの安全性と有効性を評価することを目的としており、有望な結果が得られれば、さらに重要な試験につながる可能性があります。

獣医学における予防医療への注目は高まっています。ワクチンや早期診断ツールなど、予防治療の開発を目的とした臨床試験が一般的になりつつあります。さらに、動物病院や研究機関は、犬の希少がんに特化した専門的な臨床試験の取り組みを開始しています。これらの臨床試験は、個々の犬の遺伝子プロファイルに合わせた標的療法、免疫療法、精密医療技術などの新しい治療アプローチを調査することを目的としています。

獣医臨床試験市場レポートハイライト

  • 獣医学における継続的な進歩が、動物の健康と福祉を向上させるための獣医臨床試験の需要を促進しています。さらに、主要企業による動物医療の革新に向けた研究開発投資の拡大が、市場の需要を押し上げると予想されます。
  • 動物の種類別では、コンパニオンアニマルセグメンテーションが2023年の市場を独占し、今後数年間で9.5%の最速成長率を示すと予測されています。さらに、コンパニオンアニマルの中では、イヌセグメントが2023年に最も高い市場シェアを占めています。
  • 適応症別では、腫瘍学分野が2023年に27.51%のシェアで市場を独占したが、これは動物におけるがんの有病率の上昇と獣医腫瘍学の研究開発投資の増加によるものです。一方、内科セグメントは、今後数年間で10.2%以上の最も速い速度で成長すると予想されています。
  • スポンサーに基づくと、製薬会社およびバイオ製薬会社セグメントが2023年の市場を独占し、学術機関および研究センターセグメントは今後数年間で9.8%超の最速成長率が見込まれています。
  • 2023年の介入タイプ別市場シェアは医薬品が最大を占めました。しかし、医療機器セグメントは近い将来10.0%前後の最も高い成長率を示すと推定されます。
  • 2023年の地域別市場シェアは、北米が33.70%と最も高かったです。アジア太平洋地域は、今後数年間で10.1%以上の最速成長率が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 獣医臨床試験市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
  • 獣医臨床試験市場分析ツール
  • COVID-19分析
  • 主要国別の推定ペット数

第4章 獣医臨床試験市場: 動物別推定・動向分析

  • セグメントダッシュボード
  • 世界の獣医臨床試験市場の変動分析
  • 世界の獣医臨床試験市場規模と動向分析、動物別、2018~2030年
  • ペット
  • 家畜
  • その他の動物

第5章 獣医臨床試験市場:適応症別推定・動向分析

  • セグメントダッシュボード
  • 世界の獣医臨床試験市場の変動分析
  • 世界の獣医臨床試験市場規模と動向分析、適応症別、2018~2030年
  • 腫瘍学
  • 内科
  • 整形外科
  • 心臓病学
  • 神経学
  • 眼科
  • 皮膚科
  • その他適応症

第6章 獣医臨床試験市場:介入別推定・動向分析

  • セグメントダッシュボード
  • 世界の獣医臨床試験市場の変動分析
  • 世界の獣医臨床試験市場規模と動向分析、介入別、2018~2030年
  • 薬剤
  • 医療機器
  • その他

第7章 獣医臨床試験市場: スポンサー別推定・動向分析

  • セグメントダッシュボード
  • 世界の獣医臨床試験市場の変動分析
  • 世界の獣医臨床試験市場規模と動向分析、スポンサー別、2018~2030年
  • 製薬およびバイオ医薬品企業
  • 学術研究センター
  • その他

第8章 獣医臨床試験市場:地域別推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測および動向分析、2018年~2030年
  • 北米
    • 市場推計・予測、2018年~2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 市場推計・予測、2018年~2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
  • アジア太平洋
    • 市場推計・予測、2018年~2030年
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 市場推計・予測、2018年~2030年
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 市場推計・予測、2018年~2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 市場参入企業の分類
  • 企業市況分析/ヒートマップ分析
  • 2023年の企業市場シェアの推定分析
  • 戦略マッピング
    • 合併と買収
    • パートナーシップとコラボレーション
    • その他
  • 企業プロファイル
    • Charles River Laboratory
    • IDEXX Laboratories, Inc.
    • Cebiphar.
    • Argenta.
    • Bioagile Therapeutics Pvt. Ltd.
    • Veterinary Research Management.
    • Clinvet.
    • Labcorp Drug Development.
    • OCR-Oncovet Clinical Research.
    • Vivesto AB.

第10章 要点

図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 4 Global Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 5 Global Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 6 Global Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 7 Global Veterinary Clinical Trials Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 10 North America Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 11 North America Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 12 North America Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 13 U.S. Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 14 U.S. Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 15 U.S. Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 16 U.S. Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 17 Canada Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 19 Canada Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 20 Canada Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 21 Mexico Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 22 Mexico Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 23 Mexico Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 24 Mexico Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 25 Europe Veterinary Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 27 Europe Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 28 Europe Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 29 Europe Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 31 Germany Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 32 Germany Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 33 Germany Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 34 UK Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 35 UK Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 36 UK Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 37 UK Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 38 France Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 39 France Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 40 France Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 41 France Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 42 Italy Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 43 Italy Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 44 Italy Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 45 Italy Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 46 Spain Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 47 Spain Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 48 Spain Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 49 Spain Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 50 Denmark Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 51 Denmark Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 52 Denmark Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 53 Denmark Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 54 Sweden Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 55 Sweden Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 56 Sweden Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 57 Sweden Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 58 Norway Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 59 Norway Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 60 Norway Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 61 Norway Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Veterinary Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 67 China Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 68 China Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 69 China Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 70 China Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 71 Japan Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 72 Japan Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 73 Japan Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 74 Japan Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 75 India Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 76 India Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 77 India Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 78 India Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 79 South Korea Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 80 South Korea Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 81 South Korea Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 82 South Korea Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 83 Australia Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 84 Australia Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 85 Australia Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 86 Australia Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 87 Thailand Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 88 Thailand Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 89 Thailand Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 90 Thailand Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 91 Latin America Veterinary Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 93 Latin America Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 94 Latin America Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 95 Latin America Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 96 Brazil Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 97 Brazil Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 98 Brazil Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 99 Brazil Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 100 Argentina Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 101 Argentina Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 102 Argentina Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 103 Argentina Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Veterinary Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 109 South Africa Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 110 South Africa Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 111 South Africa Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 112 South Africa Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 117 UAE Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 118 UAE Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 119 UAE Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 120 UAE Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Veterinary Clinical Trials Market, by Animal, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Veterinary Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Veterinary Clinical Trials Market, by Intervention, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Veterinary Clinical Trials Market, by Sponsor, 2018 - 2030 (USD Million)
  • Table 125 Company Overview
  • Table 126 Service Benchmarking
  • Table 127 Financial Performance
  • Table 128 Strategic Initiatives

List of Figures

  • Fig. 1 Veterinary Clinical Trials Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Data Analysis Models
  • Fig. 6 Market Formulation And Validation
  • Fig. 7 Data Validating & Publishing
  • Fig. 8 General methodology for a commodity flow analysis of veterinary clinical trials market
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Parent market analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market value, 2023 (USD Billion)
  • Fig. 17 Ancillary market outlook, 2023
  • Fig. 18 Veterinary Clinical Trials Market Dynamics
  • Fig. 19 Estimated animal population, 2018 - 2023 by key species and key countries
  • Fig. 20 Veterinary Clinical Trials Market: PORTER's Five Forces analysis
  • Fig. 21 Veterinary Clinical Trials Market: PESTEL analysis
  • Fig. 22 Veterinary Clinical Trials Market by Animal: Key Takeaways
  • Fig. 23 Veterinary Clinical Trials Market by Animal, 2023 & 2030
  • Fig. 24 Companion Animal market, 2018 - 2030 (USD Million)
  • Fig. 25 Canine market, 2018 - 2030 (USD Million)
  • Fig. 26 Feline market, 2018 - 2030 (USD Million)
  • Fig. 27 Equine market, 2018 - 2030 (USD Million)
  • Fig. 28 Livestock Animal market, 2018 - 2030 (USD Million)
  • Fig. 29 Other animals market, 2018 - 2030 (USD Million)
  • Fig. 30 Veterinary Clinical Trials Market by Indication: Key Takeaways
  • Fig. 31 Veterinary Clinical Trials Market by Indication, Market Share, 2023 & 2030
  • Fig. 32 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 33 Internal medicine market, 2018 - 2030 (USD Million)
  • Fig. 34 Orthopedics market, 2018 - 2030 (USD Million)
  • Fig. 35 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 36 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 37 Ophthalmology market, 2018 - 2030 (USD Million)
  • Fig. 38 Dermatology market, 2018 - 2030 (USD Million)
  • Fig. 39 Other indication market, 2018 - 2030 (USD Million)
  • Fig. 40 Veterinary Clinical Trials Market by Intervention: Key Takeaways
  • Fig. 41 Veterinary Clinical Trials Market by Intervention, Market Share, 2023 & 2030
  • Fig. 42 Medicines market, 2018 - 2030 (USD Million)
  • Fig. 43 Medical Device market, 2018 - 2030 (USD Million)
  • Fig. 44 Others market, 2018 - 2030 (USD Million)
  • Fig. 45 Veterinary Clinical Trials Market by Sponsor: Key Takeaways
  • Fig. 46 Veterinary Clinical Trials Market by Sponsor, Market Share, 2023 & 2030
  • Fig. 47 Pharmaceutical and Biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 48 Academics and Research Centers market, 2018 - 2030 (USD Million)
  • Fig. 49 Others market, 2018 - 2030 (USD Million)
  • Fig. 50 Veterinary Clinical Trials Market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 51 Regional market share analysis, 2023 & 2030
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 Regional marketplace: Key takeaways
  • Fig. 55 North America Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 U.S. Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Canada Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Mexico Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Europe Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 UK Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Germany Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 France Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Italy Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Spain Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Denmark Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Sweden Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Norway Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Asia Pacific Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 China Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Japan Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 India Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Australia Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Korea Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Thailand Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Brazil Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Argentina Veterinary Clinical Trials Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 MEA Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 South Africa Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 Saudi Arabia Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 UAE Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Kuwait Veterinary Clinical Trials Market, 2018 - 2030 (USD Million)
  • Fig. 107 Market Participant Categorization
  • Fig. 108 Heat map analysis
  • Fig. 109 Strategic Framework
目次
Product Code: GVR-4-68040-329-9

Veterinary Clinical Trials Market Growth & Trends:

The global veterinary clinical trials market size is expected to reach USD 8.99 billion by 2030, exhibiting a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving industry growth include increased R&D expenditure by key players, rising prevalence of chronic diseases in animals, advancements in veterinary medicines, and rise in strategic alliances. For instance, in April 2024, Boehringer Ingelheim, a biopharmaceutical company focused on both human and animal health invested USD 593.5 Mn in animal health R&D to accelerate veterinary clinical trials as well as to develop innovative veterinary medicine.

Additionally, an increasing number of clinical trials for rare diseases in pets is expected to drive veterinary clinical trial market. Veterinary clinics and research institutions are undertaking specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques designed for individual dogs' genetic profiles. For instance, in March 2024, Vivesto AB initiated its Paccal Vet clinical trial for dogs with splenic hemangiosarcoma, marking a significant step toward addressing this challenging cancer type in canines. The trial aims to assess the safety and efficacy of Paccal Vet, formulated with XR-17 technology, with promising results potentially leading to further pivotal studies.

There is a growing focus on preventive care in veterinary medicine. Clinical trials aimed at developing preventive treatments, such as vaccines and early diagnostic tools, are becoming more common. Furthermore, veterinary clinics and research institutions are launching specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques tailored to individual dogs' genetic profiles.

Veterinary Clinical Trials Market Report Highlights:

  • Ongoing advancements in veterinary medicine drive the demand for veterinary clinical trials to improve animal health and welfare. Additionally, growing R&D investments by key players to innovate veterinary medicine are expected to boost market demand.
  • By animal type,companion animal segment dominated the market in 2023 and is projected to witness the fastest growth rate of 9.5% in the coming years. Furthermore, among companion animals, canines segment is holding highest market share in 2023.
  • In terms of indication, oncology segment dominated the market with a share of 27.51% in 2023, owing to the rising prevalence of cancers in animals and growing R&D investment for veterinary oncology. Whereas internal medicine segment is expected to grow at the fastest rate of over 10.2% in the coming years.
  • Based on the sponsor, pharmaceutical and biopharmaceutical companies segment dominated the market in 2023, and the academics and research centers segment is expected to grow at the fastest rate of over 9.8% in the coming years.
  • Medicines accounted for the largest market share by intervention type in 2023. However, medical device segment is estimated to witness the highest growth rate of around 10.0% in the near future.
  • In 2023, North America held the highest share of 33.70% of the market by region. The Asia Pacific region is expected to grow at the fastest rate of over 10.1% in the coming years.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis
    • 1.6.2. Global Market: CAGR Calculation
  • 1.7. Research Scope and Assumptions
    • 1.7.1. List of Secondary Sources
    • 1.7.2. List of Primary Sources
    • 1.7.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Clinical Trials Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing Pet Population & Expenditure
      • 3.2.1.2. Rising Prevalence Of Chronic Diseases in Animals
      • 3.2.1.3. Growing Advancement In Technology
      • 3.2.1.4. Increase in RD Expenditure
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Stringent Regulatory Requirements
      • 3.2.2.2. High Cost of Clinical Trials
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Veterinary Clinical Trials Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal landscape
  • 3.4. Covid-19 Analysis
  • 3.5. Estimated Pet Population, by key countries

Chapter 4. Veterinary Clinical Trials Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Veterinary Clinical Trials Market Movement Analysis
  • 4.3. Global Veterinary Clinical Trials Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
  • 4.4. Companion Animal
    • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Canine
      • 4.4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Feline
      • 4.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Equine
      • 4.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Livestock Animal
    • 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other animals
    • 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Clinical Trials Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Veterinary Clinical Trials Market Movement Analysis
  • 5.3. Global Veterinary Clinical Trials Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Internal medicine
    • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Orthopedics
    • 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Cardiology
    • 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. Neurology
    • 5.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.9. Ophthalmology
    • 5.9.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.10. Dermatology
    • 5.10.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others Indication
    • 5.11.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Clinical Trials Market: Intervention Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Veterinary Clinical Trials Market Movement Analysis
  • 6.3. Global Veterinary Clinical Trials Market Size & Trend Analysis, by Intervention, 2018 to 2030 (USD Million)
  • 6.4. Medicines
    • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Medical Device
    • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Clinical Trials Market: Sponsor Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Veterinary Clinical Trials Market Movement Analysis
  • 7.3. Global Veterinary Clinical Trials Market Size & Trend Analysis, Sponsor, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical and Biopharmaceutical companies
    • 7.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Academics and Research centers
    • 7.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Clinical Trials Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030 North America
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Insights
      • 8.3.2.3. U.S. Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Insights
      • 8.3.3.3. Canada Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Insights
      • 8.3.4.3. Mexico Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.K.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Insights
      • 8.4.2.3. U.K. Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Insights
      • 8.4.3.3. Germany Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Insights
      • 8.4.4.3. France Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Insights
      • 8.4.5.3. Italy Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Insights
      • 8.4.6.3. Spain Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Insights
      • 8.4.7.3. Sweden Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Insights
      • 8.4.8.3. Denmark Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Insights
      • 8.4.9.3. Norway Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Insights
      • 8.5.2.3. China Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Insights
      • 8.5.3.3. Japan Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Insights
      • 8.5.4.3. India Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Insights
      • 8.5.5.3. South Korea Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Insights
      • 8.5.6.3. Australia Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Insights
      • 8.5.7.3. Thailand Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Insights
      • 8.6.2.3. Brazil Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Insights
      • 8.6.3.3. Argentina Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East and Africa
    • 8.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Insights
      • 8.7.2.3. Saudi Arabia Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. South Africa
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Insights
      • 8.7.3.3. South Africa Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Insights
      • 8.7.4.3. UAE Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Insights
      • 8.7.5.3. Kuwait Veterinary Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis
  • 9.3. Estimated Company Market Share Analysis, 2023
  • 9.4. Strategy Mapping
    • 9.4.1. Mergers & Acquisitions
    • 9.4.2. Partnerships & Collaborations
    • 9.4.3. Others
  • 9.5. Company Profiles
    • 9.5.1. Charles River Laboratory
      • 9.5.1.1. Participant's Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. IDEXX Laboratories, Inc.
      • 9.5.2.1. Participant's Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Cebiphar.
      • 9.5.3.1. Participant's Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Argenta.
      • 9.5.4.1. Participant's Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Bioagile Therapeutics Pvt. Ltd.
      • 9.5.5.1. Participant's Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Veterinary Research Management.
      • 9.5.6.1. Participant's Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Clinvet.
      • 9.5.7.1. Participant's Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Labcorp Drug Development.
      • 9.5.8.1. Participant's Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. OCR - Oncovet Clinical Research.
      • 9.5.9.1. Participant's Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Vivesto AB.
      • 9.5.10.1. Participant's Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

Chapter 10. Key Takeaways